SlideShare a Scribd company logo
bcn checkpoint 
V I H - S I D A ▪ I T S ▪ S E X U A L I T A T ▪ H O M E S ▪ S A L U T 
Results and Next Steps 
Michael Meulbroek 
Projecte dels NOMS-Hispanosida 
Challenges and opportunities for community testing centres 
Barcelona, 5 October de 2014
BCN Checkpoint opened in 2006
Results 
2007 2008 2009 2010 2011 2012 2013 
1. Number of tests 1.065 1.228 2.485 3.425 3.837 5.051 5.062 
2. Persons tested 903 1.124 2.201 2.896 3.198 4.049 4.030 
3. HIV positive 37 72 113 126 132 138 138 
4. % HIV positive 4,1% 6,4% 5,1% 4,4% 4,1% 3,4% 3,4% 
5. Persons at first visit BCN Checkpoint 850 957 1.583 1.722 1.689 1.717 1.682 
6. HIV positive at first visit 36 53 91 100 90 92 78 
7. % HIV positive at first visit 4,2% 5,5% 5,7% 5,8% 5,3% 5,4% 4,6%
Impact of BCN Checkpoint 
2007 2008 2009 2010 2011 2012 
2013 * 
(Prov.) 
1. Number of tests 1.098 1.272 2.483 3.453 3.962 5.051 5.062 
2. Persons tested 951 1.162 2.197 2.896 3.198 4.049 4.030 
3. HIV positive 37 72 113 126 132 138 138 
8. Total HIV cases in MSM reported in 
Catalonia 
319 300 280 360 374 430 357 
9. % of cases detected in 
BCN Checkpoint 
11,6% 24,0% 40,4% 35,0% 35,3% 32,1% 38,7% 
* Data Ceeiscat 3rd October 2014
Early detection 
• 31% of the new HIV cases detected in BCN Checkpoint are recent 
infections (< 6 months) 
• 57% of the new cases are infections < 12 months
Linkage to HIV unit (2009-2013) 
665 persons 
HIV reactive tests 
633 persons 
HIV reactive tests 
562 persons 
linked to care 
14 previously HIV positive 
71 persons 
non-linked 
24 persons returned 
to country of origin 
18 false positive 
33 persons 
Excluded: 
self-linked to care 
88,8% 
14 persons 
lost 
2,2% 3,8% 5,2%
Next Steps 
Community Research
Results Check-ear (2009-2014) 
Prevalence higher than in 
the general population 
• 250 participants 
• 16% prevalence asymptomatic STIs at 
baseline (1/6) 
• Gonorrhea (rectum 5,6% / penis 2,0%) 
• Chlamydia (rectum 6,3% / penis 3,1%)
Results Check-ear (2009-2014) 
Alternative effector-function profiling 
identifies broad HIV-specific T-cell 
responses in highly HIV-exposed 
individuals who remain uninfected. 
Ruiz-Riol M, Llano A, Ibarrondo J, Zamarreño J, Yusim 
K, Bach V, Mothe B, Perez-Alvarez S, Fernandez MA, 
Requena G, Meulbroek M, Pujol F, Leon A, Cobarsi P, 
Korber BT, Clotet B, Ganoza C, Sanchez J, Coll J, 
Brander C. 
Journal Infectious Diseases 2014 Sep 23. pii: jiu534
Next Steps 
Implementation of new services: 
 Syphilis, Chlamydia, Gonorrhea and HCV testing 
 Hepatitis A and B vaccination
The ÍTACA Cohort 
(December 2008 – December 2013) 
8.165 participants - 4.481 persons with follow-up visit 
223 infections HIV 
Incidence HIV: 2,43 x 100 persons/year 
(95% CI: 2,13 – 2,77) 
General population: incidence = 0,02%
Match prediction with reality? 
Prevalence and Awareness of HIV Infection Among Men Who Have Sex With Men — 
21 Cities, United States, 2008 (MMWR, Sept. 24, 2010, 59(37) 1201-7) 
Ronald Stall, PhD. Best Practices in HIV 
Prevention: Translating Innovation into 
Action. Boston, September 27, 2013
Next Steps 
So, we know what means an high HIV incidence… 
What are the behavior surveys we need? 
“HIV is increasing among MSM not because of greater risk-taking 
behavior, but simply because HIV is so prevalent among their sex partners 
that even one or two slip-ups can have devastating consequences.” 
Susan Buchbinder 
FDA Advisory Committee for PrEP approval 
10th May 2012
The effectiveness of condoms is limited / has peaked 
Uso del preservativo 
Siempre 714 56,3% 
Casi siempre 476 37,5% 
A veces 34 2,7% 
Casi nunca 15 1,2% 
Nunca 17 1,3% 
No contesta 13 1,0% 
Total 1,269 
Estudio Ítaca - BCN Checkpoint (2008-2011) 
93,8%
What can reduce HIV incidence? 
A. Phillips. MSM in the UK: Prevention Effects of ART in Perspective. 21st CROI, Boston, abstract 116, 2014
The problem: acute infections 
Source: Galvin/Cohen, 2004
Next Steps: more regular testing
Next Steps: use HIV RNA assay
Next Steps: Pre-Exposure Prophylaxis
Acknowledgements

More Related Content

What's hot

HIV self-testing and linkage in Africa
HIV self-testing and linkage in AfricaHIV self-testing and linkage in Africa
HIV self-testing and linkage in Africa
Cheryl Johnson
 
Michael Ison - USA -Tuesday 29 - Donor Risk
Michael Ison  - USA -Tuesday 29 - Donor RiskMichael Ison  - USA -Tuesday 29 - Donor Risk
Michael Ison - USA -Tuesday 29 - Donor Riskincucai_isodp
 
Scaling-up harm reduction services to prevention HIV among people who inject ...
Scaling-up harm reduction services to prevention HIV among people who inject ...Scaling-up harm reduction services to prevention HIV among people who inject ...
Scaling-up harm reduction services to prevention HIV among people who inject ...
European Centre for Disease Prevention and Control
 
Facilitating HIV testing and linkage to care - the UK experience
Facilitating HIV testing and linkage to care - the UK experienceFacilitating HIV testing and linkage to care - the UK experience
Facilitating HIV testing and linkage to care - the UK experience
European Centre for Disease Prevention and Control
 
The Kenya HIV Testing Services Guidelines 2015
The Kenya HIV Testing Services Guidelines 2015The Kenya HIV Testing Services Guidelines 2015
The Kenya HIV Testing Services Guidelines 2015
Cheryl Johnson
 
05 gilbert marksummit 2011
05 gilbert marksummit 201105 gilbert marksummit 2011
05 gilbert marksummit 2011CBRC
 
Rapid HIV Testing: Policy & Regulatory Issues
Rapid HIV Testing: Policy & Regulatory IssuesRapid HIV Testing: Policy & Regulatory Issues
Rapid HIV Testing: Policy & Regulatory Issues
Australian Federation of AIDS Organisations
 
Scaling up HIV treatment - the Malta experience
Scaling up HIV treatment - the Malta experienceScaling up HIV treatment - the Malta experience
Scaling up HIV treatment - the Malta experience
European Centre for Disease Prevention and Control
 
Importance of HIV testing and linkage to care
Importance of HIV testing and linkage to careImportance of HIV testing and linkage to care
Importance of HIV testing and linkage to care
European Centre for Disease Prevention and Control
 
Self-testing for HIV: initial experience of the UK’s first kit
Self-testing for HIV: initial experience of the UK’s first kitSelf-testing for HIV: initial experience of the UK’s first kit
Self-testing for HIV: initial experience of the UK’s first kit
Carmen Figueroa
 
Where are we on HIV testing services - the achievements and the gaps
Where are we on HIV testing services - the achievements and the gapsWhere are we on HIV testing services - the achievements and the gaps
Where are we on HIV testing services - the achievements and the gaps
Cheryl Johnson
 
03.19.21 | Updates in HIV Prevention from Virtual CROI 2021
03.19.21 | Updates in HIV Prevention from Virtual CROI 202103.19.21 | Updates in HIV Prevention from Virtual CROI 2021
03.19.21 | Updates in HIV Prevention from Virtual CROI 2021
UC San Diego AntiViral Research Center
 
PARASITIC INFECTIONS ...
                                               PARASITIC INFECTIONS          ...                                               PARASITIC INFECTIONS          ...
HIV self-testing increases HIV testing frequency among high risk MSM: a rando...
HIV self-testing increases HIV testing frequency among high risk MSM: a rando...HIV self-testing increases HIV testing frequency among high risk MSM: a rando...
HIV self-testing increases HIV testing frequency among high risk MSM: a rando...
Cheryl Johnson
 
Launch of Policy Cures: Improving Access to Diagnostics in the Developing Wor...
Launch of Policy Cures: Improving Access to Diagnostics in the Developing Wor...Launch of Policy Cures: Improving Access to Diagnostics in the Developing Wor...
Launch of Policy Cures: Improving Access to Diagnostics in the Developing Wor...LIDC
 
Testing technologies and STI testing
Testing technologies and STI testingTesting technologies and STI testing
Testing technologies and STI testing
ReShape
 
HCV Treatment Access across Europe - Raquel Peck
HCV Treatment Access across Europe - Raquel PeckHCV Treatment Access across Europe - Raquel Peck
HCV Treatment Access across Europe - Raquel Peck
ReShape
 
Extending advanced testing services to diagnose early HIV infection in gay me...
Extending advanced testing services to diagnose early HIV infection in gay me...Extending advanced testing services to diagnose early HIV infection in gay me...
Extending advanced testing services to diagnose early HIV infection in gay me...
CBRC
 
HIV: Reaching the 90-90-90 targets in europe
HIV: Reaching the 90-90-90 targets in europeHIV: Reaching the 90-90-90 targets in europe
HIV: Reaching the 90-90-90 targets in europe
European Centre for Disease Prevention and Control
 

What's hot (20)

HIV self-testing and linkage in Africa
HIV self-testing and linkage in AfricaHIV self-testing and linkage in Africa
HIV self-testing and linkage in Africa
 
Michael Ison - USA -Tuesday 29 - Donor Risk
Michael Ison  - USA -Tuesday 29 - Donor RiskMichael Ison  - USA -Tuesday 29 - Donor Risk
Michael Ison - USA -Tuesday 29 - Donor Risk
 
Scaling-up harm reduction services to prevention HIV among people who inject ...
Scaling-up harm reduction services to prevention HIV among people who inject ...Scaling-up harm reduction services to prevention HIV among people who inject ...
Scaling-up harm reduction services to prevention HIV among people who inject ...
 
Facilitating HIV testing and linkage to care - the UK experience
Facilitating HIV testing and linkage to care - the UK experienceFacilitating HIV testing and linkage to care - the UK experience
Facilitating HIV testing and linkage to care - the UK experience
 
The Kenya HIV Testing Services Guidelines 2015
The Kenya HIV Testing Services Guidelines 2015The Kenya HIV Testing Services Guidelines 2015
The Kenya HIV Testing Services Guidelines 2015
 
10 Years of ACTS
10 Years of ACTS10 Years of ACTS
10 Years of ACTS
 
05 gilbert marksummit 2011
05 gilbert marksummit 201105 gilbert marksummit 2011
05 gilbert marksummit 2011
 
Rapid HIV Testing: Policy & Regulatory Issues
Rapid HIV Testing: Policy & Regulatory IssuesRapid HIV Testing: Policy & Regulatory Issues
Rapid HIV Testing: Policy & Regulatory Issues
 
Scaling up HIV treatment - the Malta experience
Scaling up HIV treatment - the Malta experienceScaling up HIV treatment - the Malta experience
Scaling up HIV treatment - the Malta experience
 
Importance of HIV testing and linkage to care
Importance of HIV testing and linkage to careImportance of HIV testing and linkage to care
Importance of HIV testing and linkage to care
 
Self-testing for HIV: initial experience of the UK’s first kit
Self-testing for HIV: initial experience of the UK’s first kitSelf-testing for HIV: initial experience of the UK’s first kit
Self-testing for HIV: initial experience of the UK’s first kit
 
Where are we on HIV testing services - the achievements and the gaps
Where are we on HIV testing services - the achievements and the gapsWhere are we on HIV testing services - the achievements and the gaps
Where are we on HIV testing services - the achievements and the gaps
 
03.19.21 | Updates in HIV Prevention from Virtual CROI 2021
03.19.21 | Updates in HIV Prevention from Virtual CROI 202103.19.21 | Updates in HIV Prevention from Virtual CROI 2021
03.19.21 | Updates in HIV Prevention from Virtual CROI 2021
 
PARASITIC INFECTIONS ...
                                               PARASITIC INFECTIONS          ...                                               PARASITIC INFECTIONS          ...
PARASITIC INFECTIONS ...
 
HIV self-testing increases HIV testing frequency among high risk MSM: a rando...
HIV self-testing increases HIV testing frequency among high risk MSM: a rando...HIV self-testing increases HIV testing frequency among high risk MSM: a rando...
HIV self-testing increases HIV testing frequency among high risk MSM: a rando...
 
Launch of Policy Cures: Improving Access to Diagnostics in the Developing Wor...
Launch of Policy Cures: Improving Access to Diagnostics in the Developing Wor...Launch of Policy Cures: Improving Access to Diagnostics in the Developing Wor...
Launch of Policy Cures: Improving Access to Diagnostics in the Developing Wor...
 
Testing technologies and STI testing
Testing technologies and STI testingTesting technologies and STI testing
Testing technologies and STI testing
 
HCV Treatment Access across Europe - Raquel Peck
HCV Treatment Access across Europe - Raquel PeckHCV Treatment Access across Europe - Raquel Peck
HCV Treatment Access across Europe - Raquel Peck
 
Extending advanced testing services to diagnose early HIV infection in gay me...
Extending advanced testing services to diagnose early HIV infection in gay me...Extending advanced testing services to diagnose early HIV infection in gay me...
Extending advanced testing services to diagnose early HIV infection in gay me...
 
HIV: Reaching the 90-90-90 targets in europe
HIV: Reaching the 90-90-90 targets in europeHIV: Reaching the 90-90-90 targets in europe
HIV: Reaching the 90-90-90 targets in europe
 

Viewers also liked

Analysing movie posters.docx
Analysing movie posters.docxAnalysing movie posters.docx
Analysing movie posters.docxlillymayb
 
công ty dịch vụ giúp việc gia đình trọn gói ở hồ chí minh
công ty dịch vụ giúp việc gia đình trọn gói ở hồ chí minhcông ty dịch vụ giúp việc gia đình trọn gói ở hồ chí minh
công ty dịch vụ giúp việc gia đình trọn gói ở hồ chí minhsavanna501
 
Skye Research project
Skye Research projectSkye Research project
Skye Research projectSkye Lodge
 
Mi ple como me veo y me ven en la red.
Mi ple como me veo y me ven en la red.Mi ple como me veo y me ven en la red.
Mi ple como me veo y me ven en la red.
victormanuellongoria
 
ROCK 4 PAWS ONE PAGE
ROCK 4 PAWS ONE PAGEROCK 4 PAWS ONE PAGE
ROCK 4 PAWS ONE PAGEKassie Green
 
Articulo 2
Articulo 2Articulo 2
Articulo 2
atenitas12
 
History test 4medio urbano rural y poblacion
History test 4medio urbano rural y poblacionHistory test 4medio urbano rural y poblacion
History test 4medio urbano rural y poblacion
cotepineiro
 
European ChemSex Forum Report
European ChemSex Forum ReportEuropean ChemSex Forum Report
European ChemSex Forum Report
ReShape
 
TWCBC Dedicated Internet Access (DIA) Service Level Agreement_FINAL
TWCBC Dedicated Internet Access (DIA) Service Level Agreement_FINALTWCBC Dedicated Internet Access (DIA) Service Level Agreement_FINAL
TWCBC Dedicated Internet Access (DIA) Service Level Agreement_FINALStuart Burns
 
Radial vs Axial ventilation
Radial vs Axial ventilationRadial vs Axial ventilation
Radial vs Axial ventilation
sagnikroychowdhury
 
ChemSex across Germany - What's known and what's not
ChemSex across Germany - What's known and what's notChemSex across Germany - What's known and what's not
ChemSex across Germany - What's known and what's not
ReShape
 
The ChemSex phenomenon
The ChemSex phenomenonThe ChemSex phenomenon
The ChemSex phenomenon
ReShape
 
Towards a ChemSex map: Overview of data and evidence
Towards a ChemSex map: Overview of data and evidenceTowards a ChemSex map: Overview of data and evidence
Towards a ChemSex map: Overview of data and evidence
ReShape
 
ChemSex and Injecting
ChemSex and InjectingChemSex and Injecting
ChemSex and Injecting
ReShape
 
Consent & Responsibility: a UK Perspective
Consent & Responsibility: a UK PerspectiveConsent & Responsibility: a UK Perspective
Consent & Responsibility: a UK Perspective
ReShape
 

Viewers also liked (19)

MyosMuscleHealth
MyosMuscleHealthMyosMuscleHealth
MyosMuscleHealth
 
Analysing movie posters.docx
Analysing movie posters.docxAnalysing movie posters.docx
Analysing movie posters.docx
 
công ty dịch vụ giúp việc gia đình trọn gói ở hồ chí minh
công ty dịch vụ giúp việc gia đình trọn gói ở hồ chí minhcông ty dịch vụ giúp việc gia đình trọn gói ở hồ chí minh
công ty dịch vụ giúp việc gia đình trọn gói ở hồ chí minh
 
4
44
4
 
Skye Research project
Skye Research projectSkye Research project
Skye Research project
 
Kenneth W Finney
Kenneth W FinneyKenneth W Finney
Kenneth W Finney
 
Mi ple como me veo y me ven en la red.
Mi ple como me veo y me ven en la red.Mi ple como me veo y me ven en la red.
Mi ple como me veo y me ven en la red.
 
ROCK 4 PAWS ONE PAGE
ROCK 4 PAWS ONE PAGEROCK 4 PAWS ONE PAGE
ROCK 4 PAWS ONE PAGE
 
KMSU - June2015
KMSU - June2015KMSU - June2015
KMSU - June2015
 
Articulo 2
Articulo 2Articulo 2
Articulo 2
 
History test 4medio urbano rural y poblacion
History test 4medio urbano rural y poblacionHistory test 4medio urbano rural y poblacion
History test 4medio urbano rural y poblacion
 
European ChemSex Forum Report
European ChemSex Forum ReportEuropean ChemSex Forum Report
European ChemSex Forum Report
 
TWCBC Dedicated Internet Access (DIA) Service Level Agreement_FINAL
TWCBC Dedicated Internet Access (DIA) Service Level Agreement_FINALTWCBC Dedicated Internet Access (DIA) Service Level Agreement_FINAL
TWCBC Dedicated Internet Access (DIA) Service Level Agreement_FINAL
 
Radial vs Axial ventilation
Radial vs Axial ventilationRadial vs Axial ventilation
Radial vs Axial ventilation
 
ChemSex across Germany - What's known and what's not
ChemSex across Germany - What's known and what's notChemSex across Germany - What's known and what's not
ChemSex across Germany - What's known and what's not
 
The ChemSex phenomenon
The ChemSex phenomenonThe ChemSex phenomenon
The ChemSex phenomenon
 
Towards a ChemSex map: Overview of data and evidence
Towards a ChemSex map: Overview of data and evidenceTowards a ChemSex map: Overview of data and evidence
Towards a ChemSex map: Overview of data and evidence
 
ChemSex and Injecting
ChemSex and InjectingChemSex and Injecting
ChemSex and Injecting
 
Consent & Responsibility: a UK Perspective
Consent & Responsibility: a UK PerspectiveConsent & Responsibility: a UK Perspective
Consent & Responsibility: a UK Perspective
 

Similar to Bcn checkpoint - Michael Meulbroek

A Decade of Behavioral HIV Prevention and Care Engagement Research in Uganda:...
A Decade of Behavioral HIV Prevention and Care Engagement Research in Uganda:...A Decade of Behavioral HIV Prevention and Care Engagement Research in Uganda:...
A Decade of Behavioral HIV Prevention and Care Engagement Research in Uganda:...
UC San Diego AntiViral Research Center
 
Screening for syphilis
Screening for syphilisScreening for syphilis
Optimal HIV testing strategies to achieve high levels of HIV diagnosis in Sou...
Optimal HIV testing strategies to achieve high levels of HIV diagnosis in Sou...Optimal HIV testing strategies to achieve high levels of HIV diagnosis in Sou...
Optimal HIV testing strategies to achieve high levels of HIV diagnosis in Sou...
Carmen Figueroa
 
HPV infection and anal dysplasia in Vancouver: findings from the ManCount Survey.
HPV infection and anal dysplasia in Vancouver: findings from the ManCount Survey.HPV infection and anal dysplasia in Vancouver: findings from the ManCount Survey.
HPV infection and anal dysplasia in Vancouver: findings from the ManCount Survey.
CBRC
 
Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"
Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"
Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"
HopkinsCFAR
 
Colloque RI 2014 : Intervention de Michael B. POTTER, MD, (University of Cali...
Colloque RI 2014 : Intervention de Michael B. POTTER, MD, (University of Cali...Colloque RI 2014 : Intervention de Michael B. POTTER, MD, (University of Cali...
Colloque RI 2014 : Intervention de Michael B. POTTER, MD, (University of Cali...
Institut national du cancer
 
Using Data to Improve Linkage to Care
Using Data to Improve Linkage to CareUsing Data to Improve Linkage to Care
Using Data to Improve Linkage to Care
Randi Sylve
 
Using Data to Improve LTC - Debbie Wendell
Using Data to Improve LTC -  Debbie WendellUsing Data to Improve LTC -  Debbie Wendell
Using Data to Improve LTC - Debbie Wendell
Louisiana STD/HIV Program (LAOPH/SHP)
 
Epidemiology of gonorrhoea
Epidemiology of gonorrhoeaEpidemiology of gonorrhoea
Epidemiology of gonorrhoea
Josep Vidal-Alaball
 
Realizing the potential for HIV self-testing - a summary of latest evidence
Realizing the potential for HIV self-testing - a summary of latest evidenceRealizing the potential for HIV self-testing - a summary of latest evidence
Realizing the potential for HIV self-testing - a summary of latest evidence
Cheryl Johnson
 
Chris Beyrer: "State of the Science: Key populations"
Chris Beyrer: "State of the Science: Key populations"Chris Beyrer: "State of the Science: Key populations"
Chris Beyrer: "State of the Science: Key populations"
HopkinsCFAR
 
Антиретровирусное лечение – перспективы Европейского клинического общества по...
Антиретровирусное лечение – перспективы Европейского клинического общества по...Антиретровирусное лечение – перспективы Европейского клинического общества по...
Антиретровирусное лечение – перспективы Европейского клинического общества по...
hivlifeinfo
 
Men's Health & Primary Care: Improving Access and Outcomes
Men's Health & Primary Care: Improving Access and OutcomesMen's Health & Primary Care: Improving Access and Outcomes
Men's Health & Primary Care: Improving Access and Outcomes
Men's Health Forum
 
Cost of testing per new HIV diagnosis as a metric for monitoring cost-effecti...
Cost of testing per new HIV diagnosis as a metric for monitoring cost-effecti...Cost of testing per new HIV diagnosis as a metric for monitoring cost-effecti...
Cost of testing per new HIV diagnosis as a metric for monitoring cost-effecti...
Carmen Figueroa
 
Victorian HIV Service STI Project
Victorian HIV Service STI ProjectVictorian HIV Service STI Project
Victorian HIV Service STI Project
Australian Federation of AIDS Organisations
 
Colloque RI 2014 : Intervention de David W. BAKER, MD, MPH (Feinberg School o...
Colloque RI 2014 : Intervention de David W. BAKER, MD, MPH (Feinberg School o...Colloque RI 2014 : Intervention de David W. BAKER, MD, MPH (Feinberg School o...
Colloque RI 2014 : Intervention de David W. BAKER, MD, MPH (Feinberg School o...
Institut national du cancer
 
PPT Castelli "Dall'HIV all'AIDS fino alla coinfezione: una diagnosi difficile?"
PPT Castelli "Dall'HIV all'AIDS fino alla coinfezione: una diagnosi difficile?"PPT Castelli "Dall'HIV all'AIDS fino alla coinfezione: una diagnosi difficile?"
PPT Castelli "Dall'HIV all'AIDS fino alla coinfezione: una diagnosi difficile?"StopTb Italia
 
Prof. Ran Balicer, Director, Clalit Research Institute, Health Policy Plannin...
Prof. Ran Balicer, Director, Clalit Research Institute, Health Policy Plannin...Prof. Ran Balicer, Director, Clalit Research Institute, Health Policy Plannin...
Prof. Ran Balicer, Director, Clalit Research Institute, Health Policy Plannin...
IBM Cúram Software Health and Social Programs
 
Self testing seminar overall
Self testing seminar overallSelf testing seminar overall
Self testing seminar overallHIVScotland
 

Similar to Bcn checkpoint - Michael Meulbroek (20)

A Decade of Behavioral HIV Prevention and Care Engagement Research in Uganda:...
A Decade of Behavioral HIV Prevention and Care Engagement Research in Uganda:...A Decade of Behavioral HIV Prevention and Care Engagement Research in Uganda:...
A Decade of Behavioral HIV Prevention and Care Engagement Research in Uganda:...
 
Screening for syphilis
Screening for syphilisScreening for syphilis
Screening for syphilis
 
Optimal HIV testing strategies to achieve high levels of HIV diagnosis in Sou...
Optimal HIV testing strategies to achieve high levels of HIV diagnosis in Sou...Optimal HIV testing strategies to achieve high levels of HIV diagnosis in Sou...
Optimal HIV testing strategies to achieve high levels of HIV diagnosis in Sou...
 
HPV infection and anal dysplasia in Vancouver: findings from the ManCount Survey.
HPV infection and anal dysplasia in Vancouver: findings from the ManCount Survey.HPV infection and anal dysplasia in Vancouver: findings from the ManCount Survey.
HPV infection and anal dysplasia in Vancouver: findings from the ManCount Survey.
 
Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"
Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"
Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"
 
Colloque RI 2014 : Intervention de Michael B. POTTER, MD, (University of Cali...
Colloque RI 2014 : Intervention de Michael B. POTTER, MD, (University of Cali...Colloque RI 2014 : Intervention de Michael B. POTTER, MD, (University of Cali...
Colloque RI 2014 : Intervention de Michael B. POTTER, MD, (University of Cali...
 
Using Data to Improve Linkage to Care
Using Data to Improve Linkage to CareUsing Data to Improve Linkage to Care
Using Data to Improve Linkage to Care
 
Using Data to Improve LTC - Debbie Wendell
Using Data to Improve LTC -  Debbie WendellUsing Data to Improve LTC -  Debbie Wendell
Using Data to Improve LTC - Debbie Wendell
 
Epidemiology of gonorrhoea
Epidemiology of gonorrhoeaEpidemiology of gonorrhoea
Epidemiology of gonorrhoea
 
Realizing the potential for HIV self-testing - a summary of latest evidence
Realizing the potential for HIV self-testing - a summary of latest evidenceRealizing the potential for HIV self-testing - a summary of latest evidence
Realizing the potential for HIV self-testing - a summary of latest evidence
 
Chris Beyrer: "State of the Science: Key populations"
Chris Beyrer: "State of the Science: Key populations"Chris Beyrer: "State of the Science: Key populations"
Chris Beyrer: "State of the Science: Key populations"
 
Антиретровирусное лечение – перспективы Европейского клинического общества по...
Антиретровирусное лечение – перспективы Европейского клинического общества по...Антиретровирусное лечение – перспективы Европейского клинического общества по...
Антиретровирусное лечение – перспективы Европейского клинического общества по...
 
Men's Health & Primary Care: Improving Access and Outcomes
Men's Health & Primary Care: Improving Access and OutcomesMen's Health & Primary Care: Improving Access and Outcomes
Men's Health & Primary Care: Improving Access and Outcomes
 
Cost of testing per new HIV diagnosis as a metric for monitoring cost-effecti...
Cost of testing per new HIV diagnosis as a metric for monitoring cost-effecti...Cost of testing per new HIV diagnosis as a metric for monitoring cost-effecti...
Cost of testing per new HIV diagnosis as a metric for monitoring cost-effecti...
 
Victorian HIV Service STI Project
Victorian HIV Service STI ProjectVictorian HIV Service STI Project
Victorian HIV Service STI Project
 
Journal.pone.0021528
Journal.pone.0021528Journal.pone.0021528
Journal.pone.0021528
 
Colloque RI 2014 : Intervention de David W. BAKER, MD, MPH (Feinberg School o...
Colloque RI 2014 : Intervention de David W. BAKER, MD, MPH (Feinberg School o...Colloque RI 2014 : Intervention de David W. BAKER, MD, MPH (Feinberg School o...
Colloque RI 2014 : Intervention de David W. BAKER, MD, MPH (Feinberg School o...
 
PPT Castelli "Dall'HIV all'AIDS fino alla coinfezione: una diagnosi difficile?"
PPT Castelli "Dall'HIV all'AIDS fino alla coinfezione: una diagnosi difficile?"PPT Castelli "Dall'HIV all'AIDS fino alla coinfezione: una diagnosi difficile?"
PPT Castelli "Dall'HIV all'AIDS fino alla coinfezione: una diagnosi difficile?"
 
Prof. Ran Balicer, Director, Clalit Research Institute, Health Policy Plannin...
Prof. Ran Balicer, Director, Clalit Research Institute, Health Policy Plannin...Prof. Ran Balicer, Director, Clalit Research Institute, Health Policy Plannin...
Prof. Ran Balicer, Director, Clalit Research Institute, Health Policy Plannin...
 
Self testing seminar overall
Self testing seminar overallSelf testing seminar overall
Self testing seminar overall
 

More from ReShape

European ChemSex forum report 2018
European ChemSex forum report 2018European ChemSex forum report 2018
European ChemSex forum report 2018
ReShape
 
Where's the hope? Dialogues for Solidarity - Session 4
Where's the hope? Dialogues for Solidarity - Session 4Where's the hope? Dialogues for Solidarity - Session 4
Where's the hope? Dialogues for Solidarity - Session 4
ReShape
 
Where's the hope? Dialogues for solidarity, Session 3
Where's the hope? Dialogues for solidarity, Session 3Where's the hope? Dialogues for solidarity, Session 3
Where's the hope? Dialogues for solidarity, Session 3
ReShape
 
Where's the Hope? Dialogues for Solidarity, Session 2
Where's the Hope? Dialogues for Solidarity, Session 2Where's the Hope? Dialogues for Solidarity, Session 2
Where's the Hope? Dialogues for Solidarity, Session 2
ReShape
 
Where's the hope? Dialogues for Solidarity - Session 1
Where's the hope? Dialogues for Solidarity - Session 1Where's the hope? Dialogues for Solidarity - Session 1
Where's the hope? Dialogues for Solidarity - Session 1
ReShape
 
Hepatitis C Research Gaps - Graham Cooke
Hepatitis C Research Gaps - Graham CookeHepatitis C Research Gaps - Graham Cooke
Hepatitis C Research Gaps - Graham Cooke
ReShape
 
Testing Strategies for HIV and HCV: similarities and differences - Dr Chloe O...
Testing Strategies for HIV and HCV: similarities and differences - Dr Chloe O...Testing Strategies for HIV and HCV: similarities and differences - Dr Chloe O...
Testing Strategies for HIV and HCV: similarities and differences - Dr Chloe O...
ReShape
 
The HIV Cascade - Dr Laura Waters
The HIV Cascade - Dr Laura WatersThe HIV Cascade - Dr Laura Waters
The HIV Cascade - Dr Laura Waters
ReShape
 
New Treatment for hepatitis C: Impact on morbidity and mortality - Dr Helen H...
New Treatment for hepatitis C: Impact on morbidity and mortality - Dr Helen H...New Treatment for hepatitis C: Impact on morbidity and mortality - Dr Helen H...
New Treatment for hepatitis C: Impact on morbidity and mortality - Dr Helen H...
ReShape
 
Hepatitis C Generic Drugs - Stuart Flanagan
Hepatitis C Generic Drugs - Stuart FlanaganHepatitis C Generic Drugs - Stuart Flanagan
Hepatitis C Generic Drugs - Stuart Flanagan
ReShape
 
G monitor sheet
G monitor sheetG monitor sheet
G monitor sheet
ReShape
 
Outreach and community engagement. Supporting & resourcing the gay community ...
Outreach and community engagement. Supporting & resourcing the gay community ...Outreach and community engagement. Supporting & resourcing the gay community ...
Outreach and community engagement. Supporting & resourcing the gay community ...
ReShape
 
ChemSex
ChemSexChemSex
ChemSex
ReShape
 
ChemSex: a community policy response
ChemSex: a community policy responseChemSex: a community policy response
ChemSex: a community policy response
ReShape
 
ChemSex in therapy
ChemSex in therapyChemSex in therapy
ChemSex in therapy
ReShape
 
ChemSex - Early Interventions Considerations
ChemSex - Early Interventions ConsiderationsChemSex - Early Interventions Considerations
ChemSex - Early Interventions Considerations
ReShape
 
Siegfried Schwarze
Siegfried Schwarze Siegfried Schwarze
Siegfried Schwarze
ReShape
 
Psychosexual issues and ChemSex
Psychosexual issues and ChemSexPsychosexual issues and ChemSex
Psychosexual issues and ChemSex
ReShape
 
PrEP and ChemSex: Looking forward
PrEP and ChemSex: Looking forwardPrEP and ChemSex: Looking forward
PrEP and ChemSex: Looking forward
ReShape
 
Club Drug Clinic, Project Neptune and the G Trial
Club Drug Clinic, Project Neptune and the G TrialClub Drug Clinic, Project Neptune and the G Trial
Club Drug Clinic, Project Neptune and the G Trial
ReShape
 

More from ReShape (20)

European ChemSex forum report 2018
European ChemSex forum report 2018European ChemSex forum report 2018
European ChemSex forum report 2018
 
Where's the hope? Dialogues for Solidarity - Session 4
Where's the hope? Dialogues for Solidarity - Session 4Where's the hope? Dialogues for Solidarity - Session 4
Where's the hope? Dialogues for Solidarity - Session 4
 
Where's the hope? Dialogues for solidarity, Session 3
Where's the hope? Dialogues for solidarity, Session 3Where's the hope? Dialogues for solidarity, Session 3
Where's the hope? Dialogues for solidarity, Session 3
 
Where's the Hope? Dialogues for Solidarity, Session 2
Where's the Hope? Dialogues for Solidarity, Session 2Where's the Hope? Dialogues for Solidarity, Session 2
Where's the Hope? Dialogues for Solidarity, Session 2
 
Where's the hope? Dialogues for Solidarity - Session 1
Where's the hope? Dialogues for Solidarity - Session 1Where's the hope? Dialogues for Solidarity - Session 1
Where's the hope? Dialogues for Solidarity - Session 1
 
Hepatitis C Research Gaps - Graham Cooke
Hepatitis C Research Gaps - Graham CookeHepatitis C Research Gaps - Graham Cooke
Hepatitis C Research Gaps - Graham Cooke
 
Testing Strategies for HIV and HCV: similarities and differences - Dr Chloe O...
Testing Strategies for HIV and HCV: similarities and differences - Dr Chloe O...Testing Strategies for HIV and HCV: similarities and differences - Dr Chloe O...
Testing Strategies for HIV and HCV: similarities and differences - Dr Chloe O...
 
The HIV Cascade - Dr Laura Waters
The HIV Cascade - Dr Laura WatersThe HIV Cascade - Dr Laura Waters
The HIV Cascade - Dr Laura Waters
 
New Treatment for hepatitis C: Impact on morbidity and mortality - Dr Helen H...
New Treatment for hepatitis C: Impact on morbidity and mortality - Dr Helen H...New Treatment for hepatitis C: Impact on morbidity and mortality - Dr Helen H...
New Treatment for hepatitis C: Impact on morbidity and mortality - Dr Helen H...
 
Hepatitis C Generic Drugs - Stuart Flanagan
Hepatitis C Generic Drugs - Stuart FlanaganHepatitis C Generic Drugs - Stuart Flanagan
Hepatitis C Generic Drugs - Stuart Flanagan
 
G monitor sheet
G monitor sheetG monitor sheet
G monitor sheet
 
Outreach and community engagement. Supporting & resourcing the gay community ...
Outreach and community engagement. Supporting & resourcing the gay community ...Outreach and community engagement. Supporting & resourcing the gay community ...
Outreach and community engagement. Supporting & resourcing the gay community ...
 
ChemSex
ChemSexChemSex
ChemSex
 
ChemSex: a community policy response
ChemSex: a community policy responseChemSex: a community policy response
ChemSex: a community policy response
 
ChemSex in therapy
ChemSex in therapyChemSex in therapy
ChemSex in therapy
 
ChemSex - Early Interventions Considerations
ChemSex - Early Interventions ConsiderationsChemSex - Early Interventions Considerations
ChemSex - Early Interventions Considerations
 
Siegfried Schwarze
Siegfried Schwarze Siegfried Schwarze
Siegfried Schwarze
 
Psychosexual issues and ChemSex
Psychosexual issues and ChemSexPsychosexual issues and ChemSex
Psychosexual issues and ChemSex
 
PrEP and ChemSex: Looking forward
PrEP and ChemSex: Looking forwardPrEP and ChemSex: Looking forward
PrEP and ChemSex: Looking forward
 
Club Drug Clinic, Project Neptune and the G Trial
Club Drug Clinic, Project Neptune and the G TrialClub Drug Clinic, Project Neptune and the G Trial
Club Drug Clinic, Project Neptune and the G Trial
 

Recently uploaded

Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
Sujoy Dasgupta
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
sisternakatoto
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIONDACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
DR SETH JOTHAM
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 

Recently uploaded (20)

Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIONDACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 

Bcn checkpoint - Michael Meulbroek

  • 1. bcn checkpoint V I H - S I D A ▪ I T S ▪ S E X U A L I T A T ▪ H O M E S ▪ S A L U T Results and Next Steps Michael Meulbroek Projecte dels NOMS-Hispanosida Challenges and opportunities for community testing centres Barcelona, 5 October de 2014
  • 3. Results 2007 2008 2009 2010 2011 2012 2013 1. Number of tests 1.065 1.228 2.485 3.425 3.837 5.051 5.062 2. Persons tested 903 1.124 2.201 2.896 3.198 4.049 4.030 3. HIV positive 37 72 113 126 132 138 138 4. % HIV positive 4,1% 6,4% 5,1% 4,4% 4,1% 3,4% 3,4% 5. Persons at first visit BCN Checkpoint 850 957 1.583 1.722 1.689 1.717 1.682 6. HIV positive at first visit 36 53 91 100 90 92 78 7. % HIV positive at first visit 4,2% 5,5% 5,7% 5,8% 5,3% 5,4% 4,6%
  • 4. Impact of BCN Checkpoint 2007 2008 2009 2010 2011 2012 2013 * (Prov.) 1. Number of tests 1.098 1.272 2.483 3.453 3.962 5.051 5.062 2. Persons tested 951 1.162 2.197 2.896 3.198 4.049 4.030 3. HIV positive 37 72 113 126 132 138 138 8. Total HIV cases in MSM reported in Catalonia 319 300 280 360 374 430 357 9. % of cases detected in BCN Checkpoint 11,6% 24,0% 40,4% 35,0% 35,3% 32,1% 38,7% * Data Ceeiscat 3rd October 2014
  • 5. Early detection • 31% of the new HIV cases detected in BCN Checkpoint are recent infections (< 6 months) • 57% of the new cases are infections < 12 months
  • 6. Linkage to HIV unit (2009-2013) 665 persons HIV reactive tests 633 persons HIV reactive tests 562 persons linked to care 14 previously HIV positive 71 persons non-linked 24 persons returned to country of origin 18 false positive 33 persons Excluded: self-linked to care 88,8% 14 persons lost 2,2% 3,8% 5,2%
  • 8. Results Check-ear (2009-2014) Prevalence higher than in the general population • 250 participants • 16% prevalence asymptomatic STIs at baseline (1/6) • Gonorrhea (rectum 5,6% / penis 2,0%) • Chlamydia (rectum 6,3% / penis 3,1%)
  • 9. Results Check-ear (2009-2014) Alternative effector-function profiling identifies broad HIV-specific T-cell responses in highly HIV-exposed individuals who remain uninfected. Ruiz-Riol M, Llano A, Ibarrondo J, Zamarreño J, Yusim K, Bach V, Mothe B, Perez-Alvarez S, Fernandez MA, Requena G, Meulbroek M, Pujol F, Leon A, Cobarsi P, Korber BT, Clotet B, Ganoza C, Sanchez J, Coll J, Brander C. Journal Infectious Diseases 2014 Sep 23. pii: jiu534
  • 10. Next Steps Implementation of new services:  Syphilis, Chlamydia, Gonorrhea and HCV testing  Hepatitis A and B vaccination
  • 11. The ÍTACA Cohort (December 2008 – December 2013) 8.165 participants - 4.481 persons with follow-up visit 223 infections HIV Incidence HIV: 2,43 x 100 persons/year (95% CI: 2,13 – 2,77) General population: incidence = 0,02%
  • 12. Match prediction with reality? Prevalence and Awareness of HIV Infection Among Men Who Have Sex With Men — 21 Cities, United States, 2008 (MMWR, Sept. 24, 2010, 59(37) 1201-7) Ronald Stall, PhD. Best Practices in HIV Prevention: Translating Innovation into Action. Boston, September 27, 2013
  • 13. Next Steps So, we know what means an high HIV incidence… What are the behavior surveys we need? “HIV is increasing among MSM not because of greater risk-taking behavior, but simply because HIV is so prevalent among their sex partners that even one or two slip-ups can have devastating consequences.” Susan Buchbinder FDA Advisory Committee for PrEP approval 10th May 2012
  • 14. The effectiveness of condoms is limited / has peaked Uso del preservativo Siempre 714 56,3% Casi siempre 476 37,5% A veces 34 2,7% Casi nunca 15 1,2% Nunca 17 1,3% No contesta 13 1,0% Total 1,269 Estudio Ítaca - BCN Checkpoint (2008-2011) 93,8%
  • 15. What can reduce HIV incidence? A. Phillips. MSM in the UK: Prevention Effects of ART in Perspective. 21st CROI, Boston, abstract 116, 2014
  • 16. The problem: acute infections Source: Galvin/Cohen, 2004
  • 17. Next Steps: more regular testing
  • 18. Next Steps: use HIV RNA assay